Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Wet pads and skin health: new insights for incontinence care

NCT ID NCT07164898

Knowledge-focused Sponsor: Essity Hygiene and Health AB Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at how dry and wet incontinence pad materials affect the skin barrier in healthy adults aged 65 and older. Twenty-five participants wore test patches on their forearm for two hours. Researchers measured skin moisture, pH, and water loss before and after. The goal is to help design better incontinence products that protect skin from moisture damage.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Test patches (dry or wet incontinence pad material)
What this could lead to
If successful, results could guide the design of better incontinence products that reduce skin damage from moisture.
What could go wrong
This is a small, early exploratory study with only 25 healthy participants, not patients with incontinence-associated dermatitis. Findings may not apply to real-world use or damaged skin.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

25 people

The number who actually took part.

Started

Dec 2023

Finished

Apr 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Men and women ≥ 65 years. 2. Mentally and physically able to participate in this study. 3. Written informed consent to participate in this study. 4. Intact skin on the volar forearms without skin irritation. Exclusion Criteria: 1. Have any known allergies or intolerances to one or several components of the absorbing incontinence product. 2. Suffer from excessive sweating, hyperhidrosis. 3. Have any other condition that makes participation in the clinical investigation inappropriate, as judged by investigator. 4. Not be of childbearing potential. 5. Have an alcohol and/or drug dependency.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Incontinence-associated dermatitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Incontinence-associated dermatitis

Contacts and locations

Locations

  • Essity Study Site

    Mölndal, 43131, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.